William Kim, MD (IMAGE)

UNC Lineberger Comprehensive Cancer Center

William Kim, MD

Caption

William Kim, MD, and colleagues report that adding the experimental drug entinostat to an immunotherapy-like treatment substantially boosted cancer remission in mice. This approach shows such promise that it’s already being tested in an ongoing clinical trial in people with advanced bladder cancer.

Credit

UNC Lineberger

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.